Literature DB >> 10435859

Increased sensitivity to thyroid hormone replacement therapy followed by hyponatremia and eosinophilia in a patient with long-standing young-onset primary hypothyroidism.

M Fujikawa1, K Okamura, K Sato, T Mizokami, M Shiratsuchi, M Fujishima.   

Abstract

We describe a 51-year-old woman with long-standing young-onset primary hypothyroidism. Serum cortisol, adrenocorticotropin, and arginine vasopressin levels were normal, but urinary excretion of 17-hydroxycorticosteroid was decreased. Administration of a very small initial dose of thyroid hormone induced severe acute complications including fever, palpitation, and sweating associated with a rapid decrease in serum thyrotropin level, a dramatic increase in serum alkaline-phosphatase level, and a decrease in serum total cholesterol level. A week later, the late complications of nausea, severe hyponatremia, and eosinophilia occurred. Serum cortisol level decreased slightly but remained within normal limits during this hyponatremic period. This rare case suggests that increased sensitivity to thyroid hormone can occur in long-standing primary hypothyroidism with biphasic clinical course of acute thyrotoxic complications followed by severe hyponatremia resembling hypoadrenocorticism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435859     DOI: 10.1007/BF03343593

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Impaired water excretion capacity in primary myxoedema improved by corticosteroids, corticotrophin and thyroid substitution.

Authors:  J H VOGT
Journal:  Acta Endocrinol (Copenh)       Date:  1960-10

2.  The influence of the thyroid on adrenal cortical function.

Authors:  R E PETERSON
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

3.  Addisonian crisis after thyroid replacement.

Authors:  P F Banitt; A K Munson
Journal:  Hosp Pract (Off Ed)       Date:  1986-05-15

4.  Effects of myxedema on the renal diluting and concentrating mechanism.

Authors:  V A Discala; M J Kinney
Journal:  Am J Med       Date:  1971-03       Impact factor: 4.965

5.  Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.

Authors:  H Nishitani; K Okamura; S Noguchi; K Inoue; Y Morotomi; M Fujishima
Journal:  Horm Metab Res       Date:  1990-09       Impact factor: 2.936

6.  Thyroxine administration prevents streptococcal cell wall-induced inflammatory responses.

Authors:  P A Rittenhouse; E Redei
Journal:  Endocrinology       Date:  1997-04       Impact factor: 4.736

7.  Dynamics of 24-hour endogenous cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement.

Authors:  A Iranmanesh; G Lizarralde; M L Johnson; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

8.  Life-threatening hypercalcaemia in association with Addisonian crisis.

Authors:  J Miell; W Wassif; A McGregor; J Butler; R Ross
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

9.  Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats.

Authors:  T C Kamilaris; C R DeBold; E O Johnson; E Mamalaki; S J Listwak; A E Calogero; K T Kalogeras; P W Gold; D N Orth
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

10.  Thyroid hormone-mediated regulation of corticotropin-releasing hormone messenger ribonucleic acid in the rat.

Authors:  Z X Shi; A Levy; S L Lightman
Journal:  Endocrinology       Date:  1994-03       Impact factor: 4.736

View more
  1 in total

1.  Life-threatening hyponatremia due to cessation of L-thyroxine.

Authors:  Ramazan Sari; Alper Sevinc
Journal:  J Natl Med Assoc       Date:  2003-10       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.